Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose tolerability and safety study of recombinant erythropoiesis stimulating protein in healthy adults
ChiCTR-ONC-12002771Phase 4Completed
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of recombinant erythropoiesis stimulating protein in anemia of renal disease (11 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoints: Routine hematology, Biochemistry and 1 more. Started Dec 2012; status: completed.
02
Drugs
recombinant erythropoiesis stimulating protein
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on ChiCTR-ONC-12002771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002771.